Discover insights from Nu Skin's Q4 2024 earnings call, highlighting revenue growth, innovation, and 2025 strategic priorities.

Personal care company Nu Skin (NYSE:NUS) reported Q4 CY2024 results , but sales fell by 8.8% year on year to $445.6 million.

We recently compiled a list of the Jim Cramer Shed Light on These 10 Stocks. In this article, we are going to take a look at ...